Making sense with thyroid hormone-the role of T 3 in auditory development

Nature Reviews Endocrinology

Volumn 9, Issue 5, 2013, Pages 296-307

  Ng, Lily ^a   Kelley, Matthew W ^b   Forrest, Douglas ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID HORMONE RECEPTOR;

AUDITORY NERVOUS SYSTEM; AUDITORY OSSICLE; CELL DIFFERENTIATION; CELL SPECIFICITY; COCHLEA POTENTIAL; GENETIC DISORDER; HAIR CELL; HEARING IMPAIRMENT; HUMAN; HYPOTHYROIDISM; IODINE DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSORY DYSFUNCTION; SENSORY STIMULATION;

ANIMALS; AUDITORY PATHWAYS; CELL DIFFERENTIATION; COCHLEA; COLOR VISION DEFECTS; DEAFNESS; HAIR CELLS, AUDITORY; HEARING; HUMANS; RECEPTORS, THYROID HORMONE; SIGNAL TRANSDUCTION; TRIIODOTHYRONINE;

EID: 84876780239     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.58     Document Type: Review

References (129)

1. Parker, W. R. A cretin treated by thyroid extract. Br. Med. J. 1, 333 (1896).
2. Osler, W. in Transactions of the Congress of American Physicians and Surgeons 169-206 (The Congress, Michigan, USA, 1897).
3. Refetoff, S., DeWind, L. T. & DeGroot, L. J. Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J. Clin. Endocrinol. Metab. 27, 279-294 (1967).
4. DeLong, G. R., Stanbury, J. B. & Fierro-Benitez, R. Neurological signs in congenital iodine-deficiency disorder (endemic cretinism). Dev. Med. Child Neurol. 27, 317-324 (1985).
5. Sap, J. et al. The c erbA protein is a high affinity receptor for thyroid hormone. Nature 324, 635-640 (1986).
6. Weinberger, C. et al. The c erb A gene encodes a thyroid hormone receptor. Nature 324, 641-646 (1986).
7. Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J. & Larsen, P. R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23, 38-89 (2002).
8. St Germain, D. L., Galton, V. A. & Hernandez, A. Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology 150, 1097-1107 (2009).
9. Brucker-Davis, F. et al. Prevalence and mechanisms of hearing loss in patients with resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 81, 2768-2772 (1996).
10. Ng, L. et al. A thyroid hormone receptor that is required for the development of green cone photoreceptors. Nat. Genet. 27, 94-98 (2001).
11. Gogakos, A. I., Duncan Bassett, J. H. & Williams, G. R. Thyroid and bone. Arch. Biochem. Biophys. 503, 129-136 (2010).
12. Pei, L. et al. Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome. Nat. Med. 17, 1466-1472 (2011).
13. Bernal, J. Thyroid hormone receptors in brain development and function. Nat. Clin. Pract. Endocrinol. Metab. 3, 249-259 (2007).
14. Sohmer, H. & Freeman, S. Functional development of auditory sensitivity in the fetus and neonate. J. Basic. Clin. Physiol. Pharmacol. 6, 95-108 (1995).
15. Moore, J. K. & Linthicum, F. H. Jr. The human auditory system: a timeline of development. Int. J. Audiol. 46, 460-478 (2007).
16. Katz, L. C. & Shatz, C. J. Synaptic activity and the construction of cortical circuits. Science 274, 1133-1138 (1996).
17. Hensch, T. K. Critical period regulation. Annu. Rev. Neurosci. 27, 549-579 (2004).
18. Goslings, B. M., Djokomoeljanto, R., Hoedijono, R., Soepardjo, H. & Querido, A. Studies on hearing loss in a community with endemic cretinism in Central Java, Indonesia. Acta Endocrinol. (Copenh.) 78, 705-713 (1975).
19. Deol, M. S. An experimental approach to the understanding and treatment of hereditary syndromes with congenital deafness and hypothyroidism. J. Med. Genet. 10, 235-242 (1973).
20. Uziel, A., Marot, M. & Rabie, A. Corrective effects of thyroxine on cochlear abnormalities induced by congenital hypothyroidism in the rat. II. Electrophysiological study. Dev. Brain Res. 19, 123-127 (1985).
21. Sprenkle, P. M., McGee, J., Bertoni, J. M. & Walsh, E. J. Consequences of hypothyroidism on auditory system function in Tshr mutant (hyt) mice. J. Assoc. Res. Otolaryngol. 2, 312-329 (2001).
22. Marovitz, W. F., Berryhill, B. H. & Peterson, R. R. Disruptions of bony labyrinth, ossicular chain and tympanic bullae in dwarf mice. Laryngoscope 78, 863-872 (1968).
23. Cordas, E. A. et al. Thyroid hormone receptors control developmental maturation of the middle ear and the size of the ossicular bones. Endocrinology 153, 1548-1560 (2012).
24. Dow-Edwards, D., Crane, A. M., Rosloff, B., Kennedy, C. & Sokoloff, L. Local cerebral glucose utilization in the adult cretinous rat. Brain Res. 373, 139-145 (1986).
25. Friauf, E. et al. Hypothyroidism impairs chloride homeostasis and onset of inhibitory neurotransmission in developing auditory brainstem and hippocampal neurons. Eur. J. Neurosci. 28, 2371-2380 (2008).
26. Bradley, D. J., Towle, H. C. & Young, W. S. 3rd. α and β thyroid hormone receptor (TR) gene expression during auditory neurogenesis: evidence for TR isoform-specific transcriptional regulation in vivo. Proc. Natl Acad. Sci. USA 91, 439-443 (1994).
27. Bradley, D. J., Towle, H. C. & Young, W. S. 3rd. Spatial and temporal expression of α and β thyroid hormone receptor mRNAs, including the β 2 subtype, in the developing mammalian nervous system. J. Neurosci. 12, 2288-2302 (1992).
28. Rüsch, A. et al. Retardation of cochlear maturation and impaired hair cell function caused by deletion of all known thyroid hormone receptors. J. Neurosci. 21, 9792-9800 (2001).
29. Griffith, A. J. et al. Knock-in mouse model for resistance to thyroid hormone (RTH): an RTH mutation in the thyroid hormone receptor beta gene disrupts cochlear morphogenesis. J. Assoc. Res. Otolaryngol. 3, 279-288 (2002).
30. Richter, C. P., Munscher, A., Santana Machado, D., Wondisford, F. E. & Ortiga-Carvalho, T. M. Complete activation of thyroid hormone receptor β by T3 is essential for normal cochlear function and morphology in mice. Cell Physiol. Biochem. 28, 997-1008 (2011).
31. Winter, H. et al. Thyroid hormone receptor α1 is a critical regulator for the expression of ion channels during final differentiation of outer hair cells. Histochem. Cell Biol. 128, 65-75 (2007).
32. Ferrara, A. M. et al. Homozygous thyroid hormone receptor β-gene mutations in resistance to thyroid hormone: three new cases and review of the literature. J. Clin. Endocrinol. Metab. 97, 1328-1336 (2012).
33. Bochukova, E. et al. A mutation in the thyroid hormone receptor α gene. N. Engl. J. Med. 366, 243-249 (2012).
34. van Mullem, A. et al. Clinical phenotype and mutant TRα1. N. Engl. J. Med. 366, 1451-1453 (2012).
35. Itoh, Y. et al. Brain glucose utilization in mice with a targeted mutation in the thyroid hormone α or β receptor gene. Proc. Natl Acad. Sci. USA 98, 9913-9918 (2001).
36. Ruben, R. J. Development of the inner ear of the mouse: a radioautographic study of terminal mitoses. Acta Otolaryngol. Suppl. 220, 221-244 (1967).
37. Kelley, M. W. Regulation of cell fate in the sensory epithelia of the inner ear. Nat. Rev. Neurosci. 7, 837-849 (2006).
38. Li, D., Henley, C. M. & O'Malley, B. W. Jr. Distortion product otoacoustic emissions and outer hair cell defects in the hyt/hyt mutant mouse. Hear. Res. 138, 65-72 (1999).
39. Christ, S. et al. Hearing loss in athyroid pax8 knockout mice and effects of thyroxine substitution. Audiol. Neurootol. 9, 88-106 (2004).
40. Song, L., McGee, J. A. & Walsh, E. J. Consequences of combined maternal, fetal and persistent postnatal hypothyroidism on the development of auditory function in Tshrhyt mutant mice. Brain Res. 1101, 59-72 (2006).
41. Johnson, K. R. et al. Congenital hypothyroidism, dwarfism, and hearing impairment caused by a missense mutation in the mouse dual oxidase 2 gene, Duox2. Mol. Endocrinol. 21, 1593-1602 (2007).
42. Karolyi, I. J. et al. Dietary thyroid hormone replacement ameliorates hearing deficits in hypothyroid mice. Mamm. Genome 18, 596-608 (2007).
43. Van Middlesworth, L. & Norris, C. Audiogenic seizures and cochlear damage in rats after perinatal antithyroid treatment. Endocrinol. 106, 1686-1690 (1980).
44. Uziel, A. Periods of sensitivity to thyroid hormone during the development of the organ of Corti. Acta Otolaryngol. (Stockh.) 101, 23-27 (1986).
45. Rüsch, A., Erway, L., Oliver, D., Vennström, B. & Forrest, D. Thyroid hormone receptor β dependent expression of a potassium conductance in inner hair cells at the onset of hearing. Proc. Natl Acad. Sci. USA 95, 15758-15762 (1998).
46. Brandt, N. et al. Thyroid hormone deficiency affects postnatal spiking activity and expression of Ca2+ and K+ channels in rodent inner hair cells. J. Neurosci. 27, 3174-3186 (2007).
47. Sendin, G., Bulankina, A. V., Riedel, D. & Moser, T. Maturation of ribbon synapses in hair cells is driven by thyroid hormone. J. Neurosci. 27, 3163-3173 (2007).
48. Mustapha, M. et al. Deafness and permanently reduced potassium channel gene expression and function in hypothyroid Pit1dw mutants. J. Neurosci. 29, 1212-1223 (2009).
49. Szarama, K. B., Gavara, N., Petralia, R. S., Chadwick, R. S. & Kelley, M. W. Thyroid hormone increases fibroblast growth factor receptor expression and disrupts cell mechanics in the developing organ of corti. BMC Dev. Biol. 13, 6 (2013).
50. Uziel, A., Pujol, R., Legrand, C. & Legrand, J. Cochlear synaptogenesis in the hypothyroid rat. Dev. Brain Res. 7, 295-301 (1983).
51. Cantos, R., Lopez, D. E., Merchan, J. A. & Rueda, J. Olivocochlear efferent innervation of the organ of corti in hypothyroid rats. J. Comp. Neurol. 459, 454-467 (2003).
52. Hinojosa, R. A note on development of Corti's organ. Acta Otolaryngol. 84, 238-251 (1977).
53. Lukashkin, A. N., Richardson, G. P. & Russell, I. J. Multiple roles for the tectorial membrane in the active cochlea. Hear. Res. 266, 26-35 (2010).
54. Shi, Y. B., Fu, L., Hsia, S. C., Tomita, A. & Buchholz, D. Thyroid hormone regulation of apoptotic tissue remodeling during anuran metamorphosis. Cell Res. 11, 245-252 (2001).
55. Takahashi, K. et al. Caspase 3 deficiency induces hyperplasia of supporting cells and degeneration of sensory cells resulting in the hearing loss. Brain Res. 894, 359-367 (2001).
56. Rau, A., Legan, P. K. & Richardson, G. P. Tectorin mRNA expression is spatially and temporally restricted during mouse inner ear development. J. Comp. Neurol. 405, 271-280 (1999).
57. Knipper, M. et al. Thyroid hormone-deficient period prior to the onset of hearing is associated with reduced levels of beta-tectorin protein in the tectorial membrane: implication for hearing loss. J. Biol. Chem. 276, 39046-39052 (2001).
58. Tritsch, N. X., Yi, E., Gale, J. E., Glowatzki, E. & Bergles, D. E. The origin of spontaneous activity in the developing auditory system. Nature 450, 50-55 (2007).
59. Zuo, J. & Rarey, K. Responsiveness of α1 and β1 cochlear Na, K ATPase isoforms to thyroid hormone. Acta Otolaryngol. (Stockh.) 116, 422-428 (1996).
60. Ruiz-Marcos, A., Salas, J., Sanchez-Toscano, F., Escobar del Rey, F. & Morreale de Escobar, G. Effect of neonatal and adult-onset hypothyroidism on pyramidal cells of the rat auditory cortex. Dev. Brain Res. 9, 205-213 (1983).
61. Guadaño-Ferraz, A., Escámez, M., Rausell, E. & Bernal, J. Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory neurons. J. Neurosci. 19, 3430-3439 (1999).
62. Bok, J., Chang, W. & Wu, D. K. Patterning and morphogenesis of the vertebrate inner ear. Int. J. Dev. Biol. 51, 521-533 (2007).
63. Fisher, D. in Werner and Ingbar's The Thyroid (eds Braverman, L. E. & Utiger, R. D.) 974-983 (Lippincott-Raven, USA, 1996).
64. Ng, L. et al. A protective role for type 3 deiodinase, a thyroid hormone-inactivating enzyme, in cochlear development and auditory function. Endocrinology 150, 1952-1960 (2009).
65. Ng, L. et al. Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proc. Natl Acad. Sci. USA 101, 3474-3479 (2004).
66. Kaplan, M. M. & Yaskoski, K. A. Maturational patterns of iodothyronine phenolic and tyrosyl ring deiodinase activities in rat cerebrum, cerebellum, and hypothalamus. J. Clin. Invest. 67, 1208-1214 (1981).
67. Bates, J. M., St Germain, D. L. & Galton, V. A. Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology 140, 844-851 (1999).
68. Kester, M. H. et al. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J. Clin. Endocrinol. Metab. 89, 3117-3128 (2004).
69. Freeman, S., Cherny, L. & Sohmer, H. Thyroxine affects physiological and morphological development of the ear. Hear. Res. 97, 19-29 (1996).
70. Visser, W. E., Friesema, E. C., Jansen, J. & Visser, T. J. Thyroid hormone transport in and out of cells. Trends Endocrinol. Metab. 19, 50-56 (2008).
71. Sharlin, D. S., Visser, T. J. & Forrest, D. Developmental and cell-specific expression of thyroid hormone transporters in the mouse cochlea. Endocrinology 152, 5053-5064 (2011).
72. Nakashima, T. et al. Disorders of cochlear blood flow. Brain Res. Brain Res. Rev. 43, 17-28 (2003).
73. Knipper, M. et al. Thyroid hormone affects Schwann cell and oligodendrocyte gene expression at the glial transition zone of the VIIIth nerve prior to cochlea function. Development 125, 3709-3718 (1998).
74. Berbel, P., Obregon, M. J., Bernal, J., Escobar del Rey, F. & Morreale de Escobar, G. Iodine supplementation during pregnancy: a public health challenge. Trends Endocrinol. Metab. 18, 338-343 (2007).
75. Rajatanavin, R. et al. Endemic cretinism in Thailand: a multidisciplinary survey. Eur. J. Endocrinol. 137, 349-355 (1997).
76. Soriguer, F. et al. The auditory threshold in a school-age population is related to iodine intake and thyroid function. Thyroid 10, 991-999 (2000).
77. Abrams, G. M. & Larsen, P. R. Triiodothyronine and thyroxine in the serum and thyroid glands of iodine-deficient rats. J. Clin. Invest. 52, 2522-2531 (1973).
78. Yasuda, T. et al. Outcome of a baby born from a mother with acquired juvenile hypothyroidism having undetectable thyroid hormone concentrations. J. Clin. Endocrinol. Metab. 84, 2630-2632 (1999).
79. Wasserman, E. E. et al. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: an epidemiologic assessment. Am. J. Epidemiol. 167, 701-710 (2008).
80. Harris, K. B. & Pass, K. A. Increase in congenital hypothyroidism in New York State and in the United States. Mol. Genet. Metab. 91, 268-277 (2007).
81. LaFranchi, S. H. Approach to the diagnosis and treatment of neonatal hypothyroidism. J. Clin. Endocrinol. Metab. 96, 2959-2967 (2011).
82. Vanderschueren-Lodeweyckx, M., Debruyne, F., Dooms, L., Eggermont, E. & Eeckels, R. Sensorineural hearing loss in sporadic congenital hypothyroidism. Arch. Dis. Child. 58, 419-422 (1983).
83. Francois, M., Bonfils, P., Leger, J., Czernichow, P. & Narcy, P. Role of congenital hypothyroidism in hearing loss in children. J. Pediatr. 124, 444-446 (1994).
84. Rovet, J., Walker, W., Bliss, B., Buchanan, L. & Ehrlich, R. Long-term sequelae of hearing impairment in congenital hypothyroidism. J. Pediatr. 128, 776-783 (1996).
85. Parazzini, M. et al. Click-evoked otoacoustic emissions recorded from untreated congenital hypothyroid newborns. Hear. Res. 166, 136-142 (2002).
86. Wasniewska, M. et al. Hearing loss in congenital hypothalamic hypothyroidism: a wide therapeutic window. Hear. Res. 172, 87-91 (2002).
87. Groenhout, E. G. & Dorin, R. I. Generalized thyroid hormone resistance due to a deletion of the carboxy terminus of the c erbA beta receptor. Mol. Cell Endocrinol. 99, 81-88 (1994).
88. Phillips, S. A. et al. Extreme thyroid hormone resistance in a patient with a novel truncated
89. Guenther, M. G. et al. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40- repeat protein linked to deafness. Genes Dev. 14, 1048-1057 (2000).
90. Ono, S. et al. Homozygosity for a dominant negative thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 73, 990-994 (1991).
91. Frank-Raue, K. et al. Severe form of thyroid hormone resistance in a patient with homozygous/hemizygous mutation of T3 receptor gene. Eur. J. Endocrinol. 150, 819-823 (2004).
92. Dumitrescu, A. M. et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat. Genet. 37, 1247-1252 (2005).
93. Azevedo, M. F. et al. Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J. Clin. Endocrinol. Metab. 95, 4066-4071 (2010).
94. Schoenmakers, E. et al. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J. Clin. Invest. 120, 4220-4235 (2010).
95. Hamajima, T., Mushimoto, Y., Kobayashi, H., Saito, Y. & Onigata, K. Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation. Eur. J. Endocrinol. 166, 757-764 (2012).
96. Dumitrescu, A. M., Liao, X. H., Best, T. B., Brockmann, K. & Refetoff, S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am. J. Hum. Genet. 74, 168-175 (2004).
97. Friesema, E. C. et al. Association between mutations in a thyroid hormone transporter and severe X linked psychomotor retardation. Lancet 364, 1435-1437 (2004).
98. Wirth, E. K. et al. Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan Herndon Dudley syndrome. J. Neurosci. 29, 9439-9449 (2009).
99. Griffith, A. J. & Wangemann, P. Hearing loss associated with enlargement of the vestibular aqueduct: mechanistic insights from clinical phenotypes, genotypes, and mouse models. Hear. Res. 281, 11-17 (2011).
100. Fang, Q. et al. A modifier gene alleviates hypothyroidism-induced hearing impairment in Pou1f1dw dwarf mice. Genetics 189, 665-673 (2011).
101. Fang, Q., Giordimaina, A. M., Dolan, D. F., Camper, S. A. & Mustapha, M. Genetic background of Prop1(df) mutants provides remarkable protection against hypothyroidism-induced hearing impairment. J. Assoc. Res. Otolaryngol. 13, 173-184 (2012).
102. Guo, T. W. et al. Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China. J. Med. Genet. 41, 585-590 (2004).
103. Schomburg, L. Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nat. Rev. Endocrinol. 8, 160-171 (2012).
104. Newell, F. W. & Diddie, K. R. Typical monochromacy, congenital deafness, and resistance to intracellular action of thyroid hormone. Klin. Monatsbl. Augenheilkd. 171, 731-734 (1977).
105. Lindstedt, G., Lundberg, P. A., Sjogren, B., Ernest, I. & Sundquist, O. Thyroid hormone resistance in a 35-year old man with recurrent goitre. Scand. J. Clin. Lab. Invest. 42, 585-593 (1982).
106. Weiss, A. H., Kelly, J. P., Bisset, D. & Deeb, S. S. Reduced L and M and increased S cone functions in an infant with thyroid hormone resistance due to mutations in the THRβ2 gene. Ophthalmic Genet. 33, 187-195 (2012).
107. Ng, L. et al. Type 3 deiodinase, a thyroid hormone inactivating enzyme, controls survival and maturation of cone photoreceptors. J. Neurosci. 30, 3347-3357 (2010).
108. Mirabella, G. et al. Development of contrast sensitivity in infants with prenatal and neonatal thyroid hormone insufficiencies. Pediatr. Res. 57, 902-907 (2005).
109. Simic, N., Westall, C., Astzalos, E. V. & Rovet, J. Visual abilities at 6 months in preterm infants: impact of thyroid hormone deficiency and neonatal medical morbidity. Thyroid 20, 309-315 (2010).
110. Esaki, T. et al. Functional activation of cerebral metabolism in mice with mutated thyroid hormone nuclear receptors. Endocrinology 144, 4117-4122 (2003).
111. Freeman, S. & Sohmer, H. Effect of thyroxine on the development of somatosensory and visual evoked potentials in the rat. J. Neurol. Sci. 128, 143-150 (1995).
112. Auso, E. et al. Protracted expression of serotonin transporter and altered thalamocortical projections in the barrelfield of hypothyroid rats. Eur. J. Neurosci. 14, 1968-1980 (2001).
113. Laureau, E. et al. Somatosensory evoked potentials and auditory brain-stem responses in congenital hypothyroidism. I. A longitudinal study before and after treatment in six infants detected in the neonatal period. Electroencephalogr. Clin. Neurophysiol. 64, 501-510 (1986).
114. Bongers-Schokking, C. J., Colon, E. J., Hoogland, R. A., de Groot, C. J. & Van den Brande, J. L. Somatosensory evoked potentials in neonates with primary congenital hypothyroidism during the first week of therapy. Pediatr. Res. 30, 34-39 (1991).
115. Calzà, L., Forrest, D., Vennström, B. & Hökfelt, T. Expression of peptides and other neurochemical markers in hypothalamus and olfactory bulb of mice devoid of all known thyroid hormone receptors. Neuroscience 101, 1001-1012 (2000).
116. Paternostro, M. A. & Meisami, E. Essential role of thyroid hormones in maturation of olfactory receptor neurons: an immunocytochemical study of number and cytoarchitecture of OMP-positive cells in developing rats. Int. J. Dev. Neurosci. 14, 867-880 (1996).
117. Paternostro, M. A. & Meisami, E. Marked restoration of density and total number of mature (knob-bearing) olfactory receptor neurons in rats recovering from early hypothyroid-induced growth retardation. Brain Res. Dev. Brain Res. 96, 173-183 (1996).
118. McConnell, R. J., Menendez, C. E., Smith, F. R., Henkin, R. I. & Rivlin, R. S. Defects of taste and smell in patients with hypothyroidism. Am. J. Med. 59, 354-364 (1975).
119. Gordon, B. H., Wong, G. Y., Liu, J. & Rivlin, R. S. Abnormal taste preference for saccharin in hypothyroid rats. Physiol. Behav. 52, 385-388 (1992).
120. Marsh-Armstrong, N., Huang, H., Remo, B. F., Liu, T. T. & Brown, D. D. Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase. Neuron 24, 871-878 (1999).
121. Reiss, J. O. & Burd, G. D. Cellular and molecular interactions in the development of the Xenopus olfactory system. Semin. Cell Dev. Biol. 8, 171-179 (1997).
122. Allison, W. T., Dann, S. G., Veldhoen, K. M. & Hawryshyn, C. W. Degeneration and regeneration of ultraviolet cone photoreceptors during development in rainbow trout. J. Comp. Neurol. 499, 702-715 (2006).
123. Lema, S. C. & Nevitt, G. A. Evidence that thyroid hormone induces olfactory cellular proliferation in salmon during a sensitive period for imprinting. J. Exp. Biol. 207, 3317-3327 (2004).
124. Crofton, K. M. Developmental disruption of thyroid hormone: correlations with hearing dysfunction in rats. Risk Anal. 24, 1665-1671 (2004).
125. Poon, E., Powers, B. E., McAlonan, R. M., Ferguson, D. C. & Schantz, S. L. Effects of developmental exposure to polychlorinated biphenyls and/or polybrominated diphenyl ethers on cochlear function. Toxicol. Sci. 124, 161-168 (2011).
126. Haddow, J. E. et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 341, 549-555 (1999).
127. Lazarus, J. H. et al. Antenatal thyroid screening and childhood cognitive function. N. Engl. J. Med. 366, 493-501 (2012).
128. Brent, G. A. The debate over thyroid-function screening in pregnancy. N. Engl. J. Med. 366, 562-563 (2012).
129. Pujol, R., Lavigne-Rebillard, M. & Lenoir, M. in Development of the auditory system (eds Rubel, E. W., Popper, A. N. & Fay, R. R) 146-192 (Springer, Germany, 1997).